2025 HCPCS Code Q0518
Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days
TAGS: approved pharmacy prescription supplying prophylaxis| Notice | HCPCS Q0518 terminated on December 31, 2024. |
| Short Description | Supply fee hiv prep oral 90 |
| Product Note | 0129 |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 02, 2024 |
| HCPCS Action Effective Date | January 01, 2025 |
| HCPCS Pricing Indicator Code | 46 - Carrier priced (e.g., not otherwise classified, individual determination, carrier discretion, gap-filled amounts) |
| HCPCS Type Of Service Code | 9 - Other medical items or services |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q5117 - Inj., kanjinti, 10 mg
- Q5118 - Inj., zirabev, 10 mg
- Q5119 - Inj ruxience, 10 mg
- Q5120 - Inj pegfilgrastim-bmez 0.5mg
- Q5121 - Inj. avsola, 10 mg
- Q5122 - Inj, nyvepria
- Q5123 - Inj. riabni, 10 mg
- Q5124 - Inj. byooviz, 0.1 mg
- Q5125 - Inj, releuko 1 mcg
- Q5126 - Inj alymsys 10 mg
- Q5127 - Inj, stimufend, 0.5 mg
- Q5128 - Inj, cimerli, 0.1 mg
- Q5129 - Inj, vegzelma, 10 mg
- Q5130 - Inj, fylnetra, 0.5 mg
- Q5131 - Inj, idacio, 20 mg
- Q5132 - Inj, abrilada, 10 mg
- Q5133 - Inj, tofidence, 1 mg
- Q5134 - Inj, tyruko, 1 mg
- Q5135 - Inj, tyenne, 1 mg
- Q5136 - Inj. denosumab-bbdz, 1 mg